10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial-Reference-Cited by-同舟云学术

10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial

Published:2024-04 Issue: Volume:70 Page:102529
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Yang Er-Hsiang,Chen Wei-Ying,Chiang Hsueh-Chien,Li Chung-Hao,Wu I-Hsuan,Chen Po-Jun,Wu Chung-Tai,Tsai Yu-Ching^ORCID,Cheng Wei-Chun^ORCID,Huang Chien-Jui,Sheu Bor-Shyang,Cheng Hsiu-Chi^ORCID

Funder

Taiwan Ministry of Health and Welfare

National Science and Technology Council

Publisher

Elsevier BV

Reference30 articles.

1. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report;Malfertheiner;Gut,2022

2. Review article: the global emergence of Helicobacter pylori antibiotic resistance;Thung;Aliment Pharmacol Ther,2016

3. The Toronto consensus for the treatment of Helicobacter pylori infection in adults;Fallone;Gastroenterology,2016

4. ACG clinical guideline: treatment of Helicobacter pylori infection;Chey;Am J Gastroenterol,2017

5. European registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21533 patients;Nyssen;Gut,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection;American Journal of Gastroenterology;2024-09

2. Efficacy and safety of 10-day versus 14-day bismuth-containing quadruple therapy for H. pylori eradication: A systematic review and meta-analysis;2024-08-20

3. Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial;Antibiotics;2024-04-10